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Gene network approach reveals  
co-expression patterns in nasal  
and bronchial epithelium
Kai imkamp1,2,9*, Victor Bernal 3,4,9, Marco Grzegorzcyk3, Peter Horvatovich  4, 
cornelis J. Vermeulen  1,2, Irene H. Heijink1,2,5, Victor Guryev2,6, Huib A. M. Kerstjens  1,2, 
Maarten van den Berge1,2,10 & Alen faiz1,2,5,7,8,10
Nasal gene expression profiling is a new approach to investigate the airway epithelium as a biomarker 
to study the activity and treatment responses of obstructive pulmonary diseases. We investigated to 
what extent gene expression profiling of nasal brushings is similar to that of bronchial brushings. We 
performed genome wide gene expression profiling on matched nasal and bronchial epithelial brushes 
from 77 respiratory healthy individuals. To investigate differences and similarities among regulatory 
modules, network analysis was performed on correlated, differentially expressed and smoking-
related genes using Gaussian Graphical Models. Between nasal and bronchial brushes, 619 genes were 
correlated and 1692 genes were differentially expressed (false discovery rate <0.05, |Fold-change|>2). 
Network analysis of correlated genes showed pro-inflammatory pathways to be similar between the 
two locations. Focusing on smoking-related genes, cytochrome-P450 pathway related genes were 
found to be similar, supporting the concept of a detoxifying response to tobacco exposure throughout 
the airways. In contrast, cilia-related pathways were decreased in nasal compared to bronchial brushes 
when focusing on differentially expressed genes. Collectively, while there are substantial differences 
in gene expression between nasal and bronchial brushes, we also found similarities, especially in the 
response to the external factors such as smoking.
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory obstructive disorder of the airways 
that affects millions of people worldwide1. It is a complex and heterogeneous disease caused by many factors, 
including environmental particles and genetic factors leading to inflammation and metabolic disturbances. 
Currently COPD is the third most lethal disease worldwide according to World Health Organization1. It is 
mainly caused by inhalation of noxious particles e.g. cigarette smoking, air pollution or indoor cooking, but 
the disease onset and severity depend on genetic predisposition of the person affected by these environmental 
circumstances2–4.
The initial site of exposure to inhaled substances and particles is the airway epithelium and our group and 
others have demonstrated that airway gene expression signatures can serve as biomarkers to assess the activity/
severity of COPD and asthma5,6. It has also been shown that chronic exposure to tobacco smoke results in both 
reversible and irreversible changes in bronchial airway epithelial gene expression, a so-called ‘airway field of 
injury’7,8. Furthermore, we identified a bronchial gene expression signature that is associated with COPD alter-
ation and disease severity with similar gene expression changes in lung tissue affected by COPD5. These data 
allowed the first finding, which implied that bronchial gene expression obtained by bronchoscopy could be used 
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to assess the disease activity in COPD. However, bronchoscopy is an invasive procedure with a substantial burden 
to the patient, preventing its use in large populations as well as frequent sampling.
We previously demonstrated that the nasal epithelium can be used to detect changes in COPD-associated 
gene expression and showed that the nasal epithelial COPD related gene expression signature partly overlaps with 
COPD-associated bronchial epithelial gene expression9. This strengthens the hypothesis that the upper and lower 
airways have a common COPD-related gene expression profile, the united ‘airway field of injury’. Previously, 
we and others have shown that nasal and bronchial epithelium have a similar expression profile in smokers and 
never-smokers. Additionally, we have shown that expression quantitative trait loci (eQTL) are similar between the 
two compartments10. The easy availability to nasal epithelium, nasal gene expression provides the opportunity to 
assess disease-related phenotypes and determine treatment outcome.
One way to investigate this is the use of gene network modelling. In particular, Gaussian Graphical Models 
(GGMs), are a widely used network model to study protein11, and gene regulatory networks12. The GGM consists 
of nodes (e.g. genes, proteins or metabolites) interconnected by edges if their partial correlation is significantly 
different from zero. Partial correlations are correlations where the cofounding effects are removed. This is an 
advantage of GGMs compared to other models such as Relevance Networks13 or weighted gene co-expression 
network analysis (WGCNA)14, principal component analysis or clustering, which use the structure obtained from 





Age, yr 36.06 (16.23) 37.10 (15.55) 34.89 (17.10)
BMI kg/m2 23.73 (3.50) 23.91 (3.29) 23.52 (3.76)
Gender, Male/Female 41/36 25/16 16/20
Pack years**** 8.68 (13.4) 16.30 (14.63) 0
FEV1% predicted 108.14 (10.49) 106.73 (10.62) 109.75 (10.24)
Reversibility % from baseline 3.82 (3.05) 3.82 (2.64) 3.82 (3.50)
FEV1/FVC 83.06 (6.37) 81.75 (5.97) 84.54 (6.57)
RV % predicted 93.74 (17.46) 92.83 (12.99) 94.78 (21.62)
TLC % predicted 104.04 (9.42) 102.80 (9.56) 105.44 (9.19)
RV/TLC % predicted 85.62 (12.38) 85.95 (8.84) 85.25 (15.59)
Table 1. Clinical characteristics of the NORM study. BMI, body mass index; FEV1, forced expiratory volume 
in one second; FEV1/FVC, forced expiratory volume in one second/forced vital capacity; RV, residual volume; 
TLC, total lung capacity; RV/TLC, residual volume/total lung capacity. The means and standard deviations are 
shown for continuous variables. ****Independent T-test showed significant difference between the two groups 
only with a p < 0.0001.
Gene symbol rho p-value** FDR**
PSORS1C3 0.649 0 0
TEKT4P2 0.658 0 0
CYP1A1* 0.652 0 0
CYP1B1* 0.774 0 0
WBSCR27 0.653 0 0
CFD 0.673 0 0
SLC44A5 0.690 0 0
NLGN4Y 0.730 0 0
SLC7A11* 0.648 0 0
TXLNG2P 0.720 0 0
TAS2R43 0.787 0 0
GBP3 0.880 0 0
RNU5D-1 0.641 0 0
STEAP1 0.727 0 0
ABO 0.745 0 0
GSTM1 0.743 0 0
GSTT1 0.798 0 0
GUCY1B2 0.667 0 0
HLA-DMB 0.633 0 0
HLA-DQA1 0.787 0 0
Table 2. Top 20 genes correlated between nasal and bronchial brushes (FDR < 0.05). *Smoking related genes. 
**Zero (0) p-values and FDR rate means that the number is smaller than the smallest number that can be 
represented by a double format in R (i.e. <10−308).
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Pearson correlation to find similarity patterns because spurious associations are avoided. For example, a common 
regulator gene might results in similar expression patterns of the regulated genes. These patterns are then indirect 
and cannot be distinguished from the effect of the regulator. Learning the structure of a GGM (i.e. inferring the 
edges from data) is computationally feasible even for large networks, and often performs as good as other more 
demanding network models (e.g. Bayesian Networks)15. Some applications in respiratory research include GGMs 
reconstructed from expression data of asthmatic children16, asthma integrated genomic data17, COPD phenotypic 
networks18, and asthma gene – single-nucleotide polymorphism (SNP) associations19.
In the current study, we aim to investigate to what extent gene expression profiling of nasal brushings are 
similar to that of bronchial brushings, and to determine whether nasal brushing can be used as a non-invasive 
biomarker of the lower airways in the study of respiratory diseases. We used GGMs to investigate correlated and 
differentially expressed genes between the two tissues, and to identify which pathways are similar and which are 
different.
Results
patient characteristics. From the 110 respiratory healthy participants who were enrolled in the study, 77 
had matched nasal and bronchial samples. Table 1 shows the clinical characteristics of all participants and the 
comparison of current and never smokers.
Genes similar between the nose and the bronchus. Spearman correlation analyses, comparing 
the expression of individual genes between nasal and bronchial brushes, identified 619 genes (3.4% of total, 
Benjamini-Hochberg (BH)20 -adjusted p < 0.05) that were significantly correlated between bronchial and nasal 
samples. Table 2 shows the top 20 genes with correlated expression between the nasal and the bronchial epi-
thelium. As expected, X- and Y-linked genes, smoking-related genes, and genes known to have high genetic 
contribution to variation in expression, such as HLA-DRB1, were the most significantly correlated genes in this 
analysis21. For the majority of these genes (98%) expression was positively correlated between nasal and bron-
chial brushes (Fig. 1A), indicating a subset of genes with strong concordance of their expression between the two 
Figure 1. Comparison between nasal and bronchial epithelial brushes. (A) Histogram of Spearman correlation 
of each concordant gene (FDR-adjusted p < 0.05) between nasal and bronchial brushes. (B) Comparing mean 
expression from correlated and non-correlated genes (C) Comparing standard error. SD = standard error.
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sampling locations. To confirm that these findings were not by chance, a permutation analysis was conducted 
(n = 500). Indeed, the number of positively correlated genes was always found to be greater with paired samples 
compared to randomly picked (non-paired) samples (p < 0.002). Furthermore, we found that genes correlated 
between the two locations have both higher mean expression and greater variation (standard deviation) than 
non-correlated genes (Fig. 1B,C), indicating that variation of gene expression is required for correlation. We next 
investigated to what extent the nasal sample reflects an individual’s bronchial transcriptional profile rather than a 
response to environmental insults such as smoking. To this end, we assessed whether the nasal-bronchial relation 
within a patient was stronger than across patients. We performed this analysis for all genes genome-wide and for 
the list of 619 correlated genes mentioned above. We found no difference with respect to the nasal-bronchial rela-
tion between samples from the nose and bronchus when looking at all genes, while for the 619 correlated genes 
(CO), the intra-patient nasal bronchial correlations were more correlated than across patients (Fig. 2A–C). This 
may be explained by the low expression or low variation in expression in the population of the non-correlating 
genes. These two factors drive the lack of self-correlation as the levels of expression between nasal and bronchial 
brushes are very similar across all patients.
network analysis on correlated genes. From these 619 CO genes, we built two GGM networks (one for 
each tissue) at BH-adjusted p ≤ 0.01 (Fig. 3A). We found 163 genes (26.33%) that are connected in the bronchial 
network with 156 edges (i.e. significant partial correlations), and 168 (27.14%) in nasal network with 152 edges. 
In total 236 genes (38.12%) had at least one edge in one of the tissues, from which only 36 genes (15.25%) have 
common edges in both compartments.
Figure 3B shows an (edge-wise) comparison of the networks via a scatter plot of BH p-values for the CO genes. 
We observed that genes belonging to the same family tend to be interconnected in both tissues. In particular, 
HLA-DQB1, HLA-DRB1, HLA-DRB5 and HLA-DQA1 were interconnected to each other. Other gene pairs from 
the same family are connected as well, namely; (i) SAA1-SAA2, (ii) STEAP1-STEAP2, (iii) RNU5F-1 - RNU5D-
1, (iv) MT2A - MT1L, (v) CD207- CDH17. Table 3 shows the results of GO enrichment analysis for biological 
Figure 2. Correlation between nasal and bronchial epithelial brushes. (A) Heatmap showing Spearman 
correlation of genes between nasal and bronchial brushes (FDR-adjusted p < 0.05). (B) Correlation between 
independent and matched samples using all genes and (C) genes which correlate between matched samples of 
nasal and bronchial brushes.
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processes at False Discovery Rate (FDR) ≤0.05 (Fig. 3C). The enrichment consisted of 56 biological processes 
mainly related to inflammatory and immunological pathways.
network analysis on smoking-related genes. Previously, we identified 27 genes that were differentially 
expressed in current smokers compared to never smokers in both the nasal and bronchial brushes22. From these 
27 smoking-related genes (SM), we inferred two GGM networks (one for each tissue) at BH-adjusted ≤0.05 
(Fig. 4A). We found 8 genes (29.62%) that are connected in the bronchial network with 4 edges (i.e. having 
multiple significant partial correlations), and 6 genes (22.22%) in nasal network with 3 edges. A total of 6 genes 
(75.00%, 3 gene pairs) exhibited one common edge between the bronchial and nasal network. Figure 4B shows 
an (edge-wise) comparison of the networks via a scatter plot of BH p-values for the SM genes. We observed 
Figure 3. Network analyses for the correlated (CO) genes. (A) GGM network for the CO genes (BH ≤ .p 0 01). 
Genes that had no significant connections (partial correlation) were left out of the figure, and the genes 
connected in only one of the tissues are colored in grey. In blue: edges present in bronchial tissue. In red: edges 
present in nasal tissue. In magenta: edges present both tissues (Overlapped edges). (B) Scatter plot of the GGM 
network edges (partial correlation) for the CO genes. Each red dot represents −log p(BH )10  of an edge in 
bronchial tissue (horizontal axis) versus nasal tissue (vertical axis). In light black: the critical value at BH 
≤ . .p 0 01  The figure displays the respective gene pairs for the most similar edges. (C) The 50 most significant 
GOs for the set of Overlapped genes. The enrichment is contrasted against two sets of genes randomly sampled 
from the CO (619 genes) and from the whole genome (19718 genes). The panel displays the corresponding 
mean −log10 (p-values) and error bars represent + 2 standard errors over the 500 random samples.
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that two gene pairs belonging to the same family are connected in both tissues, namely; (i) SAA1-SAA2, (ii) 
CYP1A1-CYP1B1 and (iii) TFF1- FAM177B. The enrichment was observed for 22 biological processes mainly 
related to the metabolism of xenobiotics and other P450 related pathways (Fig. 4C). Table 4 shows the results of 
GO enrichment analysis for biological processes at FDR ≤ 0.05.
Transcription profiles differ between the nose and the bronchus. Next, we investigated which genes 
drive the differences between the locations. We identified 6,806 expressed in nasal and 6,797 genes expressed in 
bronchial epithelium (log2(microarray florescence) <3), with an overlap of 98.2%. Expression of 130 genes was 
specific to bronchial epithelium, while 145 genes were specifically expressed in nasal epithelium. A differential 
expression analysis identified 1692 differential expressed genes (DEGs), among which 723 (3.98%) DEGs with 
higher and 969 (5.34%) with lower expression (|log fold change|>2, FDR < 0.05) in nasal compared to bronchial 
brushes. Table 5 shows the 20 most DEGs. Figure 5A shows the DEGs highlighted in red (higher in bronchial 
brushes) and blue (lower in bronchial brushes) in a scatter plot showing the mean expression in the bronchial and 
nasal brushes. Figure 5B shows a heatmap of the DEGs.
network analysis on DeGs. From the 1692 DEGs, we built two GGM networks (one for each tissue) at 
BH-adjusted p ≤ 0.01. We found that 821 genes (48.52%) are connected in the bronchial network with 2642 edges 
(i.e. significant partial correlations), and 946 (55.91%) in nasal network with 5291 edges. We found that 1136 
genes (67.13%) have at least one significant edge in one of the tissues, from which 179 genes (15.76%) show com-
mon edges, and the remaining 957 genes (84.24%) do not exhibit common edges.
Figure 6A shows an (edge-wise) comparison of the networks for each tissue via a scatter plot of BH p-values 
for the DEGs. This set of 957 genes will be referred to as the genes with non-overlapped edges. The gene ontology 
(GO) enrichment analysis identified 160 biological processes mainly related to cilium (e.g. cilium part, organiza-
tion and assembly). The 50 most significant GOs are displayed in Fig. 6B. Table 6 shows the GO enrichment for 
biological processes at ≤ .FDR 0 05 for the non-overlapped genes.
Cell type decomposition and gene set variation analysis (GSVA) analysis. To investigate the differ-
ence in cell-type composition between bronchial and nasal epithelium, we employed markers identified in recent 
single-cell profiling of human lungs23. Interestingly, bronchial epithelium shows higher expression of genes that 
mark Ciliated and Club cells, while nasal tissue exhibits higher expression of genes characteristic for Goblet cells 
(Fig. 7A). Within tissue the expression patterns of marker genes is similar between smoker and never smokers 
where apparent difference can be observed only at the level of individual genes (e.g. MUC5B or CEACAM5). In 
addition to determine differential pathways expression we have performed GSVA of both tissue type using gene 
sets attributed to Goblet, and Ciliated cells (Fig. 7B).
Discussion
In the current study, we used a network-based approach to identify pathways that explain the differences and 
similarities between the gene expression profiles from nasal and bronchial brushes. This is the first study using 
GGMs to compare gene networks from the expression data obtained from nasal and bronchial samples. We show 
that genes involved in inflammatory pathways are retained between the two compartments, while cilia-related 
genes are lower expressed in the nose. The detoxifying gene expression response of the respiratory tract to ciga-
rette smoking is similar in the nose and bronchus.
When investigating pathways from genes with similar expression in the nose and bronchus, we found genes 
involved in pro-inflammatory pathways, including the HLA-family, CFD, CD207 and MT2A. The HLA class II 
molecules have a key function in the adaptive immune response by providing peptides to the antigen receptor 
of CD4 +T lymphocytes. Several studies have found an association between Human Leukocyte Antigen (HLA) 
class II genes and asthma, as well as with other allergic diseases, such as allergic rhinitis and atopic dermati-
tis22. Previous studies have shown similar eosinophilic infiltration (a hallmark of inflammation in asthma) in 
the nose and bronchus of healthy controls and asthmatics on corticosteroid therapy. Interestingly, although 
increased inflammation in untreated asthmatics compared to healthy controls was present in both compart-
ments, the inflammation was further enhanced in the bronchus. Furthermore, in vitro studies have shown high 
Term ID Term name p-value Intersection
KEGG:05150 Staphylococcus aureus infection 3.63·10−6 HLA-DQB1, HLA-DRB1, HLA-DQA1, CFD, HLA-DRB5
REAC:202430 Translocation of ZAP-70 to Immunological synapse 5.28·10−6 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
REAC:202427 Phosphorylation of CD3 and TCR zeta chains 1.03·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
REAC:389948 PD-1 signaling 1.26·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
GO:0042613 MHC class II protein complex 1.43·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
KEGG:05310 Asthma 1.77·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
KEGG:05330 Allograft rejection 4.48·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
KEGG:05332 Graft-versus-host disease 5.63·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
REAC:202433 Generation of second messenger molecules 6.11·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
GO:0042611 MHC protein complex 8.27·10−5 HLA-DQB1, HLA-DRB1, HLA-DQA1, HLA-DRB5
Table 3. List of top 10 enriched GOs for the overlapping genes set from the CO genes ( ≤ .FDR 0 05).
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concordance in inflammatory responses to the pro-inflammatory stimuli IL-1β, TNF-α and rhinovirus in both 
nasal and bronchial epithelium24,25. The strong concordance in gene expression networks for genes involved in 
pro-inflammatory pathways (between samples collected in the nose and the bronchus) indicates that the nasal 
epithelium could be used to study underlying molecular mechanisms of inflammation and to identify easily 
accessible biomarkers for chronic inflammatory disease classification.
Figure 4. Network analyses for the smoking (SM) genes. (A) GGM network for the SM genes (BH ≤ .p 0 05 ). 
Genes which had no significant connections (partial correlation) were left out of the figure, and the genes 
connected in only one of the tissues are colored in grey. In blue: edges present in bronchial tissue. In red: edges 
present in nasal tissue. In magenta: edges present both tissues (Overlapped edges). (B) Scatter plot of the GGM 
network edges (partial correlation) for the SM genes. Each red dot represents −log p(BH )10  of an edge in 
bronchial tissue (horizontal axis) versus nasal tissue (vertical axis). In light black: the critical value at BH 
≤ . .p 0 05  The figure displays the respective gene pairs for the most similar edges. (C) 22 significant GOs for the 
set of Overlapped genes. The enrichment is contrasted against two sets of genes randomly sampled from the SM 
(27 genes) and from the whole genome (19718 genes). The panel displays the corresponding mean 
−log10 (p-values), and error bars represent + 2 standard errors over the 500 random samples.
Term ID Term name p-value Intersection
REAC:2142670 Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) 0.000211 CYP1B1, CYP1A1
REAC:2142816 Synthesis of (16–20)-hydroxyeicosatetraenoic acids (HETE) 0.000271 CYP1B1, CYP1A1
KEGG:00380 Tryptophan metabolism 0.000539 CYP1B1, CYP1A1
KEGG:04913 Ovarian steroidogenesis 0.000847 CYP1B1, CYP1A1
KEGG:00140 Steroid hormone biosynthesis 0.00114 CYP1B1, CYP1A1
KEGG:00980 Metabolism of xenobiotics by cytochrome P450 0.00177 CYP1B1, CYP1A1
GO:0097267 omega-hydroxylase P450 pathway 0.00214 CYP1B1, CYP1A1
KEGG:05204 Chemical carcinogenesis 0.00224 CYP1B1, CYP1A1
GO:0009404 toxin metabolic process 0.00623 CYP1B1, CYP1A1
GO:0019373 epoxygenase P450 pathway 0.0125 CYP1B1, CYP1A1
Table 4. List of top 10 enriched GOs for the overlapping genes set from the SM genes ( ≤ .FDR 0 05).
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Furthermore, when looking at pathways concordantly affected by smoking between the nose and the bron-
chus, genes providing proteins with oxidoreductase activity such as the cytochrome P450 genes (e.g. CYP1A1, 
CYP1B1) and ALDH1A3, had similar expression between the nose and the bronchus. Previously, it has been 
shown that genes induced by smoking and having oxidoreductase activity are one of the most rapidly reversi-
ble genes upon smoking cessation8. Our findings further support the idea of a detoxifying response to tobacco 
exposure throughout the airways in smokers. Previous studies focusing on ex vivo nasal and bronchial biopsies 
have shown similar response to cigarette smoke stimulation between the two tissues26. Moreover, current and 
former smokers’ bronchial epithelial gene expression has been used to derive and validate a biomarker to detect 
lung cancer27. Subsequently, it was found that lung cancer-associated gene expression was detectable from nasal 
Gene symbol Log2FC p-value FDR
PAX6 3.270 3.09·10−122 3.05·10−118
CPA4 5.546 1.66·10−122 3.05·10−118
MUC21 4.275 1.46·10−118 9.62·10−115
GDPD3 3.689 7.20·10−113 3.55·10−109
CERS3 3.874 3.17·10−109 1.25·10−105
XDH 2.695 5.56·10−109 1.83·10−105
PAX3 2.726 2.69·10−108 7.59·10−105
VGLL1 3.188 1.98·10−107 4.88·10−104
C8orf34 −3.702 3.55·10−106 7.77·10−103
S100A4 2.902 8.67·10−105 1.71·10−101
PI3 3.726 2.65·10−104 4.76·10−101
SIX3 2.519 1.80·10−103 2.96·10−100
SPRR2A 6.237 2.15·10−103 3.26·10−100
FGF14 −4.115 2.88·10−102 4.05·10−99
CNTN3 −3.347 1.38·10−101 1.81·10−98
PAX7 2.797 8.88·10−101 1.09·10−97
GALNT14 2.166 1.95·10−100 2.26·10−97
ANKRD22 2.855 3.42·10−100 3.75·10−97
CD36 4.086 7.30·10−100 7.58·10−97
UCA1 5.230 9.80·10−100 9.66·10−97
Table 5. Top 20 genes differentially expressed between nasal and bronchial brushes (|Log2FC| >1.5, 
FDR < 0.05).
Figure 5. Differences between nasal and bronchial epithelial brushes. (A) Correlation plot of the mean gene 
expression from nasal and bronchial brushes with genes significantly lower and higher in bronchial brushes 
highlighted in blue and red, respectively (FDR < 0.05). (B) Heatmap of gene differentially expressed between 
nasal (blue) and bronchial (red) brushes (|Log2FC| > 1.5, FDR < 0.05).
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epithelium, with both tissue showing concordant expression alterations (e.g. regulation of apoptosis and immune 
system signaling)28.
Another gene identified in our analysis is TFF1, which encodes for the trefoil factor family peptides. These 
peptides are secreted by mucus-producing cells into mucosal surfaces throughout the body and can bind to mucin 
molecules. It has been shown in mouse studies that TFF1 expression is increased after injury of the airway epithe-
lium, suggesting a role in airway epithelial repair29. Another interesting gene is CTNNAL1, a gene that has been 
associated with cellular growth regulation and may be involved in the recovery of (bronchial) epithelial damage30.
A number of genes were found to have different expression levels at baseline in nasal and bronchial airway 
epithelium. However, we still found an overlap between the two networks, indicating that regardless of the differ-
ent baseline levels of individual genes, there may still be correlations for the gene-sets as a whole between the two 
compartments. Similar findings have been observed in in vitro models, showing different levels of certain genes 
between nasal and bronchial epithelial cultures, and nevertheless, these genes still correlated in their response to 
stimuli25. Previous studies focusing on ciliary beat frequency found that this was similar in nasal and bronchial 
epithelium31. However, pathway analysis of differentially expressed genes between nose and bronchus in our 
study indicated cilia-related pathways to be decreased in nasal compared to bronchial brushes. In line with this 
observation, it has been shown that the percentage of ciliated cells increases further down the respiratory tract as 
shown by a previous study32. This change in percentage will lead to a shift in cellular composition and an increase 
of cilia-related gene expression in the lower airways. This finding was confirmed by our GSVA were nasal epithe-
lium showed lower expression for ciliated genes compared to bronchial epithelium. These results support also the 
high quality of our nasal and bronchial epithelium dataset.
The strength of our study is the use of matched nasal and bronchial samples from a moderately powered data-
set. There are also a number of limitations associated with this study. First, from the network analysis perspective 
GGMs are limited to linear associations (partial correlation). Therefore, if a pair of genes shows a nonlinear 
relationship, the GGM might not identify these associations. Second, network inference is a multiple testing 
scenario, i.e. p genes imply performing p(p-1)/2 tests. Here, we have employed BH correction for multiple testing, 
however, it should be kept in mind that false positives (false edges) might be still present in the network structure 
regardless of the method depending on the chosen FDR error tolerance. Third, the small number of genes used 
for the enrichment analysis may have influenced the pathways we found. A subset of the genes with similar gene 
expression patterns between nasal and bronchial brushing identified in our current analysis are likely due to 
genetic polymorphisms that have effects on gene expression in general through the whole body not exclusively 
related to the tissues measured in the current manuscript.
In conclusion, we have shown that although there are differences in expression between the nasal and bron-
chial brushes, their response to external factors such as smoking seem to be concordant. Therefore, we suggest 
that the use of nasal brushes as a proxy for the bronchus is suitable to study airway epithelium at baseline and in 
response to environmental exposures.
Figure 6. Network analyses for the differentially expressed genes (DEGs). (A) Scatter plot of the GGM network 
edges (partial correlation) for the DE genes. Each red dot represents −log p(BH )10  of an edge in bronchial tissue 
(horizontal axis) versus nasal tissue (vertical axis). In light black: the critical value at BH ≤ . .p 0 01  The figure 
displays the respective gene pairs for the most similar edges. (B) The 50 most significant GOs for the set of 
Overlapped genes. The panel displays the corresponding mean −log10 (p-values), and error bars represent +2 
standard errors over the 500 random samples.
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Materials and Methods
Study participants and data processing. Data were collected from participants from the study to obtain 
NORMal values of inflammatory variables from healthy subjects (NORM) NCT00848406 and included healthy 
smokers and never-smokers. Details on the methods and study design have been previously published22. Bronchial 
and nasal brushings were collected during the same visit, using a Cellebrity bronchial brush (Boston Scientific, 
Massachusetts, USA) or a Cyto-Pak CytoSoft nasal brush (Medical Packaging Corporation, Camarillo, CA, USA). 
Samples were then randomized, labeled and run on Affymetrix Human Gene chip ST1.0 arrays as described 
previously according to manufacturer’s instructions (Thermo Fisher Scientific, Waltham, Massachusetts, USA)22. 
Microarray analyses were performed using R (v3.3.2) limma package and normalization was conducted in a 
single batch using Robust Multi-array Average (RMA). The study procedures were approved by the local medical 
ethics committee (Medisch Ethische Toetsingsingscommissie or METc) and written informed consent was given 
by all subjects. All experiments in this study were performed in accordance with relevant Dutch national and 
international guidelines and regulations.
Term ID Term name p-value Intersection
GO:0005929 cilium 4.27·10−26
PRKAR2B, DNAH9, MKS1, IFT88, DNAH5, CC2D2A, SPA17, IFT80, SPAG6, MOK, HSPB11, TEKT2, EFHC1, 
IFT27, HIF1A, GUCY2F, RPGRIP1L, CCDC114, DNAH11, TTC26, CEP41, B9D1, AKAP3, RSPH4A, MAK, 
NME5, IQCG, DNAH1, DNAH6, ALMS1, IFT46, DNAH7, IFT43, DNAL1, BBS9, IFT81, TTC21B, TEKT3, 
TAS2R4, TTBK2, TTLL9, TUBG1, MAP1B, CNGA4, DZIP1, TSGA10, TTLL7, DYNC2LI1, CCDC40, SPAG16, 
CCDC39, CETN2, WDR78, FAM49B, SPAG17, C8ORF37, WDR19, WDR66, RSPH1, SHANK2, BBS5, DNALI1, 
TMEM67, KIF27, AGBL2, TUB, DYNLRB2, TCTN2, ARL13B, TTLL6, DNAI2, CEP19, DNAH12, UNC119B, 
DNHD1, GPR157, MAATS1, AGBL4, DYNC2H1, IFT140, CERKL, SNTN, KIF19, TTC30B, DNAH10, CEP290, 
EFCAB7, TRAF3IP1, TCTEX1D2
GO:0044782 cilium organization 1.44·10−25
ZMYND10, PRKAR2B, FUZ, MKS1, IFT88, DNAH5, CC2D2A, IFT80, RFX3, PIH1D3, HSPB11, RFX2, TEKT2, 
IFT27, RPGRIP1L, CCDC114, TTC26, CEP41, B9D1, C11ORF63, RSPH4A, MAK, NME5, IQCG, DNAH1, 
DNAH6, ALMS1, IFT46, DNAH7, CNTRL, IFT43, DNAL1, BBS9, IFT81, TTC21B, TEKT3, TTBK2, FOXJ1, 
TUBG1, DZIP1, NEK1, DYNC2LI1, CCDC40, SPAG16, CCDC39, CETN2, SPAG17, WDR19, RSPH1, BBS5, 
STK36, TMEM67, KIF27, DNAAF2, PLK1, DNAAF3, DYNLRB2, TCTN2, ARL13B, DNAI2, UNC119B, DNHD1, 
CEP97, DYNC2H1, IFT140, KIF19, TTC30B, CEP290, TRAF3IP1, FGFR1OP, TCTEX1D2
GO:0060271 cilium assembly 1.69·10−25
ZMYND10, PRKAR2B, FUZ, MKS1, IFT88, DNAH5, CC2D2A, IFT80, RFX3, PIH1D3, HSPB11, RFX2, TEKT2, 
IFT27, RPGRIP1L, CCDC114, TTC26, CEP41, B9D1, C11ORF63, RSPH4A, MAK, NME5, IQCG, DNAH1, 
DNAH6, ALMS1, IFT46, DNAH7, CNTRL, IFT43, DNAL1, BBS9, IFT81, TTC21B, TEKT3, TTBK2, FOXJ1, 
TUBG1, DZIP1, NEK1, DYNC2LI1, CCDC40, SPAG16, CCDC39, CETN2, SPAG17, WDR19, RSPH1, BBS5, 
STK36, TMEM67, KIF27, DNAAF2, PLK1, DNAAF3, DYNLRB2, TCTN2, ARL13B, DNAI2, UNC119B, DNHD1, 
CEP97, DYNC2H1, IFT140, TTC30B, CEP290, TRAF3IP1, FGFR1OP, TCTEX1D2
GO:0044441 ciliary part 2.99·10−25
PRKAR2B, DNAH9, MKS1, IFT88, DNAH5, CC2D2A, SPA17, IFT80, SPAG6, MOK, HSPB11, EFHC1, IFT27, 
GUCY2F, RPGRIP1L, CCDC114, DNAH11, TTC26, CEP41, B9D1, AKAP3, RSPH4A, MAK, DNAH1, DNAH6, 
ALMS1, IFT46, DNAH7, IFT43, DNAL1, BBS9, IFT81, TTC21B, TAS2R4, TTBK2, TUBG1, MAP1B, CNGA4, 
DZIP1, DYNC2LI1, CCDC40, SPAG16, CCDC39, CETN2, WDR78, SPAG17, C8ORF37, WDR19, WDR66, RSPH1, 
SHANK2, BBS5, DNALI1, TMEM67, AGBL2, DYNLRB2, TCTN2, ARL13B, TTLL6, DNAI2, CEP19, UNC119B, 
DNHD1, GPR157, MAATS1, AGBL4, DYNC2H1, IFT140, CERKL, KIF19, TTC30B, DNAH10, CEP290, EFCAB7, 
TRAF3IP1, TCTEX1D2
GO:0007018 microtubule-based movement 5.74·10
−23
DNAH9, IFT88, DNAH5, SPA17, IFT80, RFX3, PIH1D3, HSPB11, KIF9, TEKT2, IFT27, HIF1A, CCDC114, 
DNAH11, TTC26, RSPH4A, MAK, NME5, KIF20A, DNAH1, DNAH6, IFT46, DNAH7, IFT43, IFT81, TTC21B, 
TEKT3, DLGAP5, MAP1B, DYNC2LI1, CCDC40, SPAG16, CCDC39, WDR78, UCHL1, SPAG17, FMN2, WDR19, 
AP3S2, WDR66, WDR63, STK36, KIF6, KIF27, DPCD, DYNLRB2, TTLL6, DNAI2, DNAH12, DNHD1, MAATS1, 
DYNC2H1, IFT140, KIF19, TTC30B, DNAH10, TRAF3IP1, TCTEX1D2
GO:0030031 cell projection assembly 1.63·10−21
ZMYND10, PRKAR2B, FUZ, MKS1, IFT88, VCL, DNAH5, CC2D2A, IFT80, FSCN1, RFX3, PIH1D3, HSPB11, 
RFX2, TEKT2, IFT27, RPGRIP1L, CCDC114, TTC26, CEP41, B9D1, PMP22, C11ORF63, RSPH4A, MAK, NME5, 
DPYSL3, IQCG, ARHGEF26, DNAH1, DNAH6, ALMS1, IFT46, DNAH7, CNTRL, IFT43, DNAL1, BBS9, IFT81, 
TTC21B, TEKT3, CDC42EP1, TTBK2, FOXJ1, TUBG1, EMP1, DZIP1, TSGA10, NEK1, DYNC2LI1, CCDC40, 
SPAG16, CCDC39, CETN2, SPAG17, KIT, WDR19, RSPH1, BBS5, STK36, TMEM67, KIF27, DNAAF2, PLK1, 
DNAAF3, DYNLRB2, TCTN2, ARL13B, LPAR3, DNAI2, UNC119B, DNHD1, CEP97, DYNC2H1, IFT140, 
TTC30B, CEP290, TRAF3IP1, FGFR1OP, TCTEX1D2, KLHL41
GO:0120031 plasma membrane bounded cell projection assembly 3.46·10
−21
ZMYND10, PRKAR2B, FUZ, MKS1, IFT88, VCL, DNAH5, CC2D2A, IFT80, FSCN1, RFX3, PIH1D3, HSPB11, 
RFX2, TEKT2, IFT27, RPGRIP1L, CCDC114, TTC26, CEP41, B9D1, PMP22, C11ORF63, RSPH4A, MAK, NME5, 
DPYSL3, IQCG, ARHGEF26, DNAH1, DNAH6, ALMS1, IFT46, DNAH7, CNTRL, IFT43, DNAL1, BBS9, IFT81, 
TTC21B, TEKT3, CDC42EP1, TTBK2, FOXJ1, TUBG1, EMP1, DZIP1, NEK1, DYNC2LI1, CCDC40, SPAG16, 
CCDC39, CETN2, SPAG17, KIT, WDR19, RSPH1, BBS5, STK36, TMEM67, KIF27, DNAAF2, PLK1, DNAAF3, 
DYNLRB2, TCTN2, ARL13B, LPAR3, DNAI2, UNC119B, DNHD1, CEP97, DYNC2H1, IFT140, TTC30B, CEP290, 
TRAF3IP1, FGFR1OP, TCTEX1D2, KLHL41
GO:0007017 microtubule-based process 2.01·10−18
ZMYND10, DNAH9, IFT88, DNAH5, CC2D2A, SPA17, ASPM, IFT80, RFX3, PIH1D3, HSPB11, KIF9, TEKT2, 
IFT27, HIF1A, KATNAL1, CCDC114, DNAH11, TTC26, C11ORF63, RSPH4A, MAK, NME5, KIF20A, IQCG, 
DNAH1, DNAH6, CDC20, IFT46, DNAH7, IFT43, DNAL1, IFT81, TTC21B, TEKT3, DLGAP5, GNAI1, TUBG1, 
MAP1B, GCC2, DYNC2LI1, CCDC40, SPAG16, CCDC39, PLK2, CETN2, CHEK1, DIXDC1, WDR78, UCHL1, 
SPAG17, FMN2, WDR19, AP3S2, WDR66, TPPP3, RSPH1, CCDC78, WDR63, STK36, SPICE1, KIF6, TMEM67, 
KIF27, MELK, DNAAF2, DPCD, PLK1, MAP1A, DNAAF3, DYNLRB2, TTLL6, MAP6, DNAI2, CNP, DNAH12, 
DNHD1, CEP97, MAATS1, DYNC2H1, IFT140, KIF19, TTC30B, DNAH10, TRAF3IP1, FGFR1OP, TCTEX1D2
GO:0097014 ciliary plasm 9.55·10−16
DNAH9, DNAH5, SPAG6, EFHC1, RPGRIP1L, CCDC114, DNAH11, RSPH4A, DNAH1, DNAH6, DNAH7, 
DNAL1, DYNC2LI1, CCDC40, SPAG16, CCDC39, WDR78, SPAG17, WDR66, BBS5, DNALI1, DYNLRB2, 
ARL13B, DNAI2, DNHD1, MAATS1, DYNC2H1, IFT140, KIF19, DNAH10, TRAF3IP1, TCTEX1D2
GO:0005930 axoneme 9.55−16
DNAH9, DNAH5, SPAG6, EFHC1, RPGRIP1L, CCDC114, DNAH11, RSPH4A, DNAH1, DNAH6, DNAH7, 
DNAL1, DYNC2LI1, CCDC40, SPAG16, CCDC39, WDR78, SPAG17, WDR66, BBS5, DNALI1, DYNLRB2, 
ARL13B, DNAI2, DNHD1, MAATS1, DYNC2H1, IFT140, KIF19, DNAH10, TRAF3IP1, TCTEX1D2
Table 6. List of top 10 enriched GOs for the non-overlapping genes from the DEGs ( ≤ .FDR 0 05).
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Gene expression analysis. For the nasal bronchial comparison, a gene was determined to be expressed if 
the median log2(normalized microarray florescence intensity) >3.
To identify concordant genes where variation among subjects was correlated between sampling locations, 
we applied a Spearman correlation comparing the expression of individual genes between nasal and bronchial 
brushes. To assess whether the nasal-bronchial relation within a patient was stronger than across patients, we 
applied a Spearman correlation on all paired samples and compared this to the average correlation on mis-
matched pairs. This analysis was conducted on all genes and on the correlated genes.
In order to identify genes differentially expressed between nasal and bronchial brushes, we performed a paired 
analysis, using a linear model correcting for age, gender and smoking status. Genes were considered significantly 
differentially expressed if their BH corrected p-value was <0.05 and if they had a |log fold change| > 2.
network analysis. Three different sets of genes were studied: (i) the set of CO, (ii) twenty seven smoking 
related genes previously found to be differentially expressed in both the nose and the bronchus22 (SM), and (iii) 
the set of DEGs. The expression data has been log2-tranformed and standardized (mean = 0, sd = 1) such that the 
data is normal distributed.
As our dataset involves a number of genes that is larger than the sample size, the reconstruction of a GGM (i.e. 
inferring the partial correlations) from expression data requires a shrinkage approach. This is usually known as a 
high-dimensional problem. To this end, the network analysis was performed using the R package GeneNet version 
1.2.1312 in R version 3.4.3. The test of significance for each of the GGM’s edges (i.e. the partial correlations) was 
performed with the improved method that we have published recently in Oxford Bioinformatics33. This method 
test the null-hypothesis of no partial correlation between pairs of genes, and has an accurate control of the false 
Figure 7. Cell type-specific marker analysis between bronchial and nasal epithelium. In panels of this figure, we 
investigate the difference in cell-type composition. Panel (A) shows the expression profile of genes identified in 
recent single-cell profiling of human lungs23 in a form of heatmap stratified by tissue type and smoking status. 
Bronchial epithelium shows higher expression of genes that mark Ciliated and Club cells, while nasal tissue 
exhibits higher expression of genes characteristic for Goblet cells. Within tissue expression patterns of marker 
genes is similar between smoker and never smokers where apparent difference can be observed only at the 
level of individual genes (e.g. MUC5B or CEACAM5). Panel (B) GSVA of ciliated and goblet cell genes from 
match nasal and bronchial brushes. The scatter plot shows the overall lower GSVA scores of different gene sets 
attributed to Ciliated cells in nasal samples and the overall higher GSVA scores of gene sets corresponding to 
Goblet cells.
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positives. For networks involving p number of genes there are p(p-1)/2 edges to test which is a multiple testing 
problem, thus the significance of the edges was adjusted with BH approach.
Gene ontology enrichment analysis. GO enrichment analysis was performed with the R package gPro-
fileR version 0.6.434, and its default “ontology-focused” multiple testing correction (i.e. g:SCS)35. The resulting GO 
enrichment was assessed by employing a gene sampling procedure. First, we identify which of the GGM’s edges 
were common in both of the analyzed tissues and the corresponding genes were checked for GO enrichment. 
These pairs of genes (i.e. from the common edges in nasal and bronchial networks) are denoted as the overlapped 
genes. Second, the GO enrichment from the overlapped genes are compared against the GO enrichment from 
two others sets of genes (of same size) obtained randomly. The genes of these random sets are sampled from (i) 
the whole set of protein-coding genes (19718 genes), and from (ii) their corresponding gene sets (e.g. CO, SM or 
DEG). If the number of connected genes in the network was greater than 50% its corresponding set (e.g. 50% of 
the genes in CO, SM or DEG) the sampling was omitted as the two sets are considered similar.
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